{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:58:48Z","timestamp":1791453528712,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1136\/ard.2011.150250","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T03:06:58Z","timestamp":1304392018000},"page":"1068-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Immunogenicity and safety of the 2009 non-adjuvanted influenza A\/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"70","clinical-trial-number":[{"clinical-trial-number":"nct01151644","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01151644","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Carla G S","family":"Saad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo F","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia E","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis A","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M R","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Calich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C B","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C M","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilma S T","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra G","family":"Pasoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozelio F","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan L A","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissiane K N","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percival D","family":"Sampaio-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T","family":"Caleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celio R","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Levy-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Carmo S","family":"Timenetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R","family":"Precioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2011.150250_bib1","first-page":"38","article-title":"Update: influenza activity \u2013 United States, August 30, 2009-January 9, 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1136\/ard.2011.150250_bib2","unstructured":"Centers for Disease Control and Prevention. Questions & Answers: Vaccine Selection for the 2010\u20132011 Influenza Season. http:\/\/www.cdc.gov\/flu\/about\/qa\/1011_vac_selection.htm (accessed 12 January 2011)."},{"key":"10.1136\/ard.2011.150250_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.150250_bib4","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1136\/ard.2011.150250_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/QAD.0b013e32833c6d5c","article-title":"Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals","volume":"24","author":"Tebas","year":"2010","journal-title":"AIDS"},{"key":"10.1136\/ard.2011.150250_bib6","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1097\/QAD.0b013e3283398da1","article-title":"Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients","volume":"24","author":"Bickel","year":"2010","journal-title":"AIDS"},{"key":"10.1136\/ard.2011.150250_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Issa","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1136\/ard.2011.150250_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.vaccine.2010.10.081","article-title":"A\/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity","volume":"29","author":"Lu","year":"2011","journal-title":"Vaccine"},{"key":"10.1136\/ard.2011.150250_bib9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib12","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib13","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib14","first-page":"1078","article-title":"International Study Group for Beh\u00e7et's Disease","volume":"335","author":"Criteria for diagnosis of Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1136\/ard.2011.150250_bib15","series-title":"Mixed Connective Tissue Disease and Anti-Nuclear Antibodies","first-page":"41","article-title":"Preliminary diagnostic criteria for mixed connective tissue disease","author":"Kasukawa","year":"1987"},{"key":"10.1136\/ard.2011.150250_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1136\/ard.2011.150250_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2011.150250_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.55.2.116","article-title":"Assessment of the European classification criteria for Sj\u00f6gren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sj\u00f6gren's Syndrome","volume":"55","author":"Vitali","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.150250_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib22","series-title":"Concepts and Procedures from Laboratory-Based Influenza Surveillance","author":"Kendal","year":"1982"},{"key":"10.1136\/ard.2011.150250_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)62003-1","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"375","author":"Liang","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ard.2011.150250_bib24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2011.150250_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard.2011.150250_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2011.150250_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.vaccine.2010.10.065","article-title":"Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A\/H5N1\/VN\/1203 pandemic influenza vaccine in humans","volume":"29","author":"Crowe","year":"2010","journal-title":"Vaccine"},{"key":"10.1136\/ard.2011.150250_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2008.11.032","article-title":"Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial","volume":"54","author":"Scharp\u00e9","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1136\/ard.2011.150250_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-6143.2007.02066.x","article-title":"Influenza vaccination is efficacious and safe in renal transplant recipients","volume":"8","author":"Scharp\u00e9","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1136\/ard.2011.150250_bib30","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1136\/ard.2011.150250_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/ard.2009.112813","article-title":"Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis","volume":"69","author":"Holvast","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.150250_bib32","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.vaccine.2009.01.078","article-title":"Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients","volume":"27","author":"Setti","year":"2009","journal-title":"Vaccine"},{"key":"10.1136\/ard.2011.150250_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10067-010-1373-y","article-title":"Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety","volume":"29","author":"Wiesik-Szewczyk","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2011.150250_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2006.12.004","article-title":"Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues","volume":"6","author":"Abu-Shakra","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2011.150250_bib35","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kep200","article-title":"Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study","volume":"48","author":"Holvast","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2011.150250_bib36","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/art.24679","article-title":"Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus","volume":"60","author":"Holvast","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2008.07.007","article-title":"Vaccination and autoimmune rheumatic diseases","volume":"8","author":"Conti","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2011.150250_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","article-title":"Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity","volume":"134","author":"Salemi","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2011.150250_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14460-01","volume":"14","author":"Waddington","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1136\/ard.2011.150250_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","article-title":"The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination","volume":"67","author":"Gelinck","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.150250_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","article-title":"The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"39","author":"Elkayam","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2011.150250_bib44","first-page":"183","article-title":"Influenza vaccine and autoimmunity","volume":"11","author":"Agmon-Levin","year":"2009","journal-title":"Isr Med Assoc J"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2011.150250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:55:20Z","timestamp":1737244520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724101082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0003496724101082"],"URL":"https:\/\/doi.org\/10.1136\/ard.2011.150250","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the 2009 non-adjuvanted influenza A\/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2011.150250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}